Breakthroughs for Bleeding: Updates in Treating and Managing Hemophilia

In 1982, the gene encoding factor IX (FIX) was cloned, followed by the cloning of the factor VIII (FVIII) gene in 1984. The events were a turning point for individuals with hemophilia A and...

Online Exclusives

U.K. Labour Party Plans to Regulate Pharmaceutical Market, Lower Drug Prices

The U.K. Labour Party has pledged to reform the country’s pharmaceutical market by establishing a publicly owned generic drug manufacturer and expanding the government’s...

Federal Watchdog Report Shows NIH Must Better Protect U.S. Research From...

New reports issued by the U.S. Department of Health and Human Services (HHS) inspector general show that foreign governments and corporations could profit from...

News

From the Blood Journals

Pretransplant Bridging With Blinatumomab Reduces MRD in Children With B-Cell Acute...

In a study of children with B-cell acute lymphocytic leukemia (B-ALL) who are about to undergo allogeneic hematopoietic cell transplantation (alloHCT), bridging with blinatumomab...
WIB_icon

Pegylated Interferon Leads to High Response Rates in Essential Thrombocythemia and...

According to results of a phase II study published in Blood, treatment with pegylated-interferon-α (PEG-rIFN-α) was associated with an overall response rate (ORR) of...

Multimedia

Pulling Back the Curtain: Robert A. Kyle, MD

In more from our interview with Robert A. Kyle, MD, he discusses his early decision to specialize in hematology and looks back on 70 years...

Pulling Back the Curtain: Saad Z. Usmani, MD

In more from our interview with Saad Z. Usmani, MD, he shares life lessons learned throughout his career.

Pulling Back the Curtain: Anna Schuh, MD, PhD

In more from our interview with Anna Schuh, MD, PhD, she shares her experiences volunteering with hematology patients in Tanzania.

Robert Kreitman: Delayed Versus Concurrent Rituximab in Hairy Cell Leukemia

Robert Kreitman, MD, shares results from a new study suggesting patients with hairy cell leukemia should receive rituximab concurrently with frontline cladribine.

On Location

On location

Examining Pregnancy Outcomes in Eculizumab-Treated Women With Atypical Hemolytic Uremic Syndrome

Women with atypical hemolytic uremic syndrome (aHUS) treated with eculizumab have similar pregnancy outcomes to...
On location

Patients With Hemophilia B Report Poor Bleeding Control With Extended Half-Life Factor IX Products

Extended half-life factor IX (FIX) products have been designed to prolong the time between clotting...
On location

Two Studies Support Using Concizumab as Prophylaxis in Patients With Hemophilia

Concizumab could be a safe and effective subcutaneous prophylactic treatment option for patients with hemophilia...
On location

Hemophilia B: The Next Target for Gene Therapy?

Treatment with a single dose of AMT-061, an investigational gene therapy, led to increased factor...
You Make the Call

From ASH Meeting on Hematologic Malignancies: How would you treat relapsed/refractory myeloma after transplant?

During their presentations, MHM speakers will be asking the audience how they would respond to...
You Make the Call

From ASH Meeting on Hematologic Malignancies: What are the approved options for relapsed marginal zone lymphoma?

During their presentations, MHM speakers will be asking the audience how they would respond to...

Latest Headlines

Advertisement

ASH Directions

ASH Directions

ASH Clinical News Now Available on the ASH Publications App, ABIM Changing Maintenance of...

ASH Clinical News Now Available on the ASH Publications App The American Society of Hematology (ASH) Publications app provides access to content from Blood, Blood...
ASH Directions

ASH Sickle Cell Initiative Wins Top ASAE Prize, ASH-a-Palooza 2019 Announced, and more

ASH Sickle Cell Disease Initiative Wins Top ASAE Prize The American Society of Hematology (ASH) is proud to have been named a 2019 Power of...

Sign up for our
eNewsletter!

The Society Pages

Remembering Stanley Schrier, John Hansen, and more

Remembering Stanley Schrier (1929 – 2019) Stanley Schrier, MD, a former American Society of Hematology (ASH) president who spent nearly 60 years at Stanford University’s...
The Society Pages

Remembering Eugene Frenkel, AMA Announces Reimagining Residency Initiative Award Recipients, and more

Remembering Eugene P. Frenkel (1929 – 2019) Eugene P. Frenkel, MD, a National Cancer Institute investigator known for his research linking vitamin B12 metabolism and...
The Society Pages

Remembering Gustave Eisemann, Cigall Kadoch Wins 2019 Wachtel Cancer Research Prize, and more

Remembering Gustave Eisemann (1926 – 2019) Gustave Eisemann, MD, passed away on May 26, 2019. Born in Halberstadt, Germany, Dr. Eisemann came to the U.S. in...

Breakthroughs for Bleeding: Updates in Treating and Managing Hemophilia

In 1982, the gene encoding factor IX (FIX) was cloned, followed by the cloning of the factor VIII (FVIII) gene in 1984. The events...

What Does the Future Hold for Gene Therapy in Nonmalignant Hematology?

The human genome contains about 25,000 genes that encode myriad proteins that drive the processes necessary for life. But disruptions, deletions, and mutations can...

The Other Opioid Epidemic

Federal crackdowns on opioid prescribing have shifted the crisis from overdoses to undertreatment The United States is in the grip of an opioid epidemic that...